Clinical Trials

150 enrolled

Leukemia, Lymphocytic, Chronic, B-Cell

NCT06651970 2026-04-15

Acalabrutinib Monotherapy vs Investigator's Choice of Treatment in Patients With CL Leukaemia and Heart Failure

60 enrolled

Heart Failure, Lymphatic Diseases, Leukemia, B-Cell

NCT07486713 2026-03-20

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

CNSGastrointestinalOther hematologic neoplasm

16 enrolled

Glioma, Neoplasms, Leukemia, Myeloid, Acute, Cholangiocarcinoma

NCT04877522 2026-03-06

Asciminib Roll-over Study

MyeloidOther hematologic neoplasm

347 enrolled

Blast Crisis, Myeloproliferative Disorders, Leukemia, Myelogenous, Chronic, BCR-ABL Positive

NCT06035757 2026-03-03

The Occurrence of Emergence Agitation in Pediatric Strabismus Surgery

76 enrolled

Emergence Delirium, Strabismus, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06289673 2026-03-03

Identification of Necessary Information for Treatment Induction in Newly Diagnosed Acute Lymphoblastic Leukemia/Lymphoma

850 enrolled

Leukemia, Biphenotypic, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT06370000 2026-03-02

REMAIN1

12 enrolled

Leukemia, Myeloid, Acute

NCT06876649 2026-03-02

A Master Protocol to Evaluate the Long-Term Safety of (LY3527727) Pirtobrutinib

787 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT06876662 2026-03-02

A Study of (LY3527727) Pirtobrutinib in Participants With Previously Treated Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma or Non-Hodgkin Lymphoma

279 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Lymphocytic, Chronic, B-Cell

NCT07044687 2026-01-12

Study to Assess Adverse Events and Change in Disease Activity of Oral Venetoclax in Combination With Subcutaneous (SC) or Intravenous (IV) Azacitidine in Newly Diagnosed Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Standard Induction Therapy in India

100 enrolled

Leukemia, Myeloid, Acute

NCT07016165 2025-08-22

Ciprofloxacin vs Ceftazidime for Empirical Treatment of High-Risk Neutropenic Fever in Children With Hematologic Malignancies

Classical hematologyLymphoidOther hematologic neoplasm

120 enrolled

Lymphoma, Non-Hodgkin, Leukemia, Myeloid, Acute, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Febrile Neutropenia

NCT06918054 2025-04-09

Hepatoprotective for Children and Adolescent With Acute Lymphoblastic Leukemia

42 enrolled

Leukemia, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT03844360 2025-03-30

Dose Individualization of Antineoplastic Drugs and Anti-Infective Drug in Children With Hematoplastic Disease

1,500 enrolled

Hematologic Neoplasms

NCT06571825 2024-08-26

RIC Allo-HSCT vs. Venetoclax-Based Consolidation in Elderly AML Patients After First CR

118 enrolled

Leukemia, Myeloid, Acute

NCT06410833 2024-05-16

BRRPJS

15 enrolled

Sjogren's Syndrome, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT05926063 2024-03-08

SAFE

Classical hematologyOther hematologic neoplasm

410 enrolled

Infections, Leukemia, Neutropenia, Febrile Neutropenia

NCT05682131 2023-01-12

SCCCG-R-ALL

210 enrolled

Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT02670564 2019-04-16

ALL SCTped FORUM - Pharmacogenomic Study (add-on Study)

1,000 enrolled